Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,902
Closed -$596K 1480
2025
Q4
$596K Buy
+1,902
New +$604K ﹤0.01% 886
2017
Q4
Sell
-4,759
Closed -$320K 2664
2017
Q3
$320K Sell
4,759
-4,852
-50% -$305K ﹤0.01% 1052
2017
Q2
$635K Hold
9,611
﹤0.01% 881
2017
Q1
$635K Buy
9,611
+110
+1% +$7.7K ﹤0.01% 881
2016
Q4
$670K Buy
+9,501
New +$593K ﹤0.01% 850

Other funds holding AGX

Glenmede Trust's AGX Position: Q1 2026 in Review

Glenmede Trust sold out of Argan (AGX) in Q1 2026, closing a stake of 1,902 shares — an estimated $596K sold.

Glenmede Trust first reported a position in AGX in Q4 2016 and held it in 5 quarters. The position peaked at $670K in Q4 2016. 496 funds tracked by Wall St. Rank hold AGX as of Q1 2026.

  • Glenmede Trust reported no remaining Argan position as of Q1 2026 after selling out during the quarter.
  • Glenmede Trust sold 1,902 Argan shares in Q1 2026, an estimated $596K.
  • Glenmede Trust first reported a position in Argan in Q4 2016 and held it in 5 quarters.
  • Glenmede Trust's Argan position peaked at $670K in Q4 2016.
  • 496 funds tracked by Wall St. Rank held Argan as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.